Personalized Nanocomposite-based Drug Delivery Systems: Integration of AI and 3D Printing
The integration of AI and 3D printing represents a transformative advancement in personalized nanocomposite drug delivery. These interdisciplinary approaches collectively enable precise control over drug release kinetics, dosage customization, and formulation design. Future developments focusing on regulatory standardization, ethical data use, and large-scale clinical translation will further accelerate the adoption of AI- and 3D-printing-assisted personalized drug delivery systems in clinical practice. While these technologies hold great potential for personalized and precise therapeutics, their clinical translation remains challenged by regulatory validation, manufacturing reproducibility, and data transparency requirements.
Authors
- Ghanshyam Parmar
- Chintan J. Aundhia (ORCID: https://orcid.org/0000-0002-2355-8897)
- Mamta Kumari (ORCID: https://orcid.org/0000-0002-8960-9546)
- Chitrali Talele (ORCID: https://orcid.org/0009-0009-4274-0764)
- Gaurav Gupta
Institutions
- Ajman University (AE)
- KM Shah Dental College and Hospital (IN)
- Suamandeep Vidyapeeth University (IN)
- Chitkara University (IN)
Publication Details
- Journal
- Current Drug Targets
- Published
- 2026-01-19
- DOI
- https://doi.org/10.2174/0113894501430905251210054617
- Primary Topic
- 3D Printing in Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00